These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Fatal liver cell necrosis following short-term administration of isoniazid and rifampicin to a patient already under treatment with antiepileptics]. Lenders JW; Bartelink AK; van Herwaarden CL; van Haelst UJ; van Tongeren JH Ned Tijdschr Geneeskd; 1983 Mar; 127(10):420-3. PubMed ID: 6835412 [No Abstract] [Full Text] [Related]
25. [The results of liver biopsies during rifampicin therapy (author's transl)]. Kozma D; Lapis K; Tompa A Prax Pneumol; 1976 Dec; 30(12):764-70. PubMed ID: 1013060 [No Abstract] [Full Text] [Related]
27. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children]. Dieu MJ J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047 [No Abstract] [Full Text] [Related]
28. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination]. Rossolini A; Cellesi C; Debolini A Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054 [No Abstract] [Full Text] [Related]
29. [Jaundice during rifampicin treatment]. Ollagnier C; Vallon C J Med Lyon; 1971 May; 52(120):835-6 passim. PubMed ID: 5136252 [No Abstract] [Full Text] [Related]
31. [Use of rifampicin in tuberculous patients with liver diseases]. Pozzi E; Menghini P G Ital Chemioter; 1972 Jul; 19(3):63-8. PubMed ID: 4671348 [No Abstract] [Full Text] [Related]
32. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)]. Abeledo Mezquita G; Otero Reigada MC An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341 [TBL] [Abstract][Full Text] [Related]
33. Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid. Burke M; Logan J Ir Med J; 1979 Oct; 72(10):430-4. PubMed ID: 500344 [No Abstract] [Full Text] [Related]
34. [Fulminant hepatitis in patients with mixed connective tissue disease under antitubercular treatment with hydrazide and rifampicin]. Waitzberg VR; Gayotto LC Rev Hosp Clin Fac Med Sao Paulo; 1982 Feb; 37(1):48-51. PubMed ID: 7123064 [No Abstract] [Full Text] [Related]
35. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin]. Bartmann K Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784 [No Abstract] [Full Text] [Related]
36. [Anti-tuberculosis chemotherapy and management of adverse reactions]. Kuwabara K Nihon Rinsho; 2011 Aug; 69(8):1389-93. PubMed ID: 21838035 [TBL] [Abstract][Full Text] [Related]